AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
GOOGL   1,421.37 (+0.58%)
AMZN   2,421.86 (-0.62%)
NVDA   348.71 (-3.42%)
CGC   20.01 (+3.04%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
AMD   53.19 (-3.59%)
T   30.82 (+3.15%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
DIS   120.95 (+2.48%)
NFLX   414.77 (-3.39%)
BAC   24.28 (+7.15%)
BA   144.73 (+5.24%)
Log in

NASDAQ:ALLOAllogene Therapeutics Earnings Date, Estimates & History

$49.35
-4.69 (-8.68 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$49.01
Now: $49.35
$55.00
50-Day Range
$18.89
MA: $32.45
$54.04
52-Week Range
$17.43
Now: $49.35
$55.00
Volume1.31 million shs
Average Volume859,433 shs
Market Capitalization$6.19 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.7

Earnings

Allogene Therapeutics (NASDAQ:ALLO) Earnings Information

Allogene Therapeutics last announced its quarterly earnings results on May 6th, 2020. The reported ($0.58) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.58). Allogene Therapeutics has generated ($1.83) earnings per share over the last year. Allogene Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 5th, 2020 based off prior year's report dates.

Allogene Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Allogene Therapeutics (NASDAQ:ALLO) Earnings Estimates

2020 EPS Consensus Estimate: ($2.43)
2021 EPS Consensus Estimate: ($2.69)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20205($0.68)($0.50)($0.58)
Q2 20205($0.65)($0.55)($0.59)
Q3 20206($0.65)($0.59)($0.62)
Q4 20206($0.70)($0.58)($0.65)
Q1 20213($0.71)($0.55)($0.62)
Q2 20213($0.71)($0.60)($0.65)
Q3 20213($0.72)($0.65)($0.69)
Q4 20212($0.75)($0.71)($0.73)

Allogene Therapeutics (NASDAQ ALLO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/5/2020
(Estimated)
       
5/6/20203/31/2020($0.58)($0.58)($0.50)Transcript
2/27/2020Q4 2019($0.68)($0.58)($0.58)Transcript
11/5/2019Q3($0.54)($0.50)($0.50)Transcript
8/7/2019Q2 2019($0.47)($0.4131)($0.41)N/A
5/7/20193/31/2019($0.40)($0.32)($0.32)N/A
3/8/201912/31/2018($0.25)($0.35)($0.33)Transcript
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.